TCL Archive NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas January 23, 1987
TCL Archive New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com. August 8, 2003
TCL Archive Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act May 17, 1985
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
